Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
32M
-
Shares change
-
+16.5K
-
Total reported value, excl. options
-
$214M
-
Value change
-
+$3.57M
-
Put/Call ratio
-
1.25
-
Number of buys
-
40
-
Number of sells
-
-39
-
Price
-
$6.68
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2020
107 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q4 2020.
AVADEL PHARMACEUTICALS - COM (AVDL) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.39M shares), Avoro Capital Advisors LLC (4.37M shares), Vivo Capital, LLC (3.53M shares), Polar Capital Holdings Plc (3.03M shares), BRANDES INVESTMENT PARTNERS, LP (2.96M shares), COWEN AND COMPANY, LLC (1.89M shares), GENDELL JEFFREY L (1.68M shares), RENAISSANCE TECHNOLOGIES LLC (1.05M shares), Asymmetry Capital Management, L.P. (956K shares), and Acuta Capital Partners, LLC (705K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.